Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
Background: Diabetic peripheral neuropathy (DPN), the most common microvascular complication of type-2 diabetes mellitus (T2DM), results in nontraumatic lower-limb amputations. When DPN is not detected early, disease progression is irreversible. Thus, biomarkers for diagnosing DPN are needed. Method...
Saved in:
Main Authors: | Noo Ree Cho (Author), Yeuni Yu (Author), Chang-Kyu Oh (Author), Dai Sik Ko (Author), Kyungjae Myung (Author), Yoonsung Lee (Author), Hee Sam Na (Author), Yun Hak Kim (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary on "The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus"
by: Won Kyoung Cho
Published: (2023) -
Diabetes: how to manage diabetic peripheral neuropathy
by: Megha Gandhi, et al.
Published: (2022) -
The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus
by: Piengjai Sophausvaporn, et al.
Published: (2023) -
A clinical study on the application of diabetic neuropathy index for the diagnosis and staging of diabetic peripheral neuropathy
by: O Kwang-Chun, et al.
Published: (2019) -
A clinical study on the application of diabetic neuropathy index for the diagnosis and staging of diabetic peripheral neuropathy
by: O Kwang-Chun, et al.
Published: (2019)